Healthcare / Medical Care FacilitiesBSE
$7.09
+0.32 (+4.73%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-3.5M · quality 39.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$74M
P/E
354.5x
↑EV/EBITDA
36.1x
↑ROE
0.2%
↓Gross Margin
100.0%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+272.6%
FCF CAGR
—
FCF margin
228.1%
FCF / Net income
37.82x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.9M · net income $234000.0 · FCF $8.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.9M | $3.9M | $3.9M | — | $75000.00 |
| Net Income | $234000.00 | $234000.00 | $239000.00 | $-177000.00 | $-1.6M |
| EBITDA | $1.7M | $1.7M | $1.7M | $1.2M | $395000.00 |
| EPS | — | — | 0.02 | -0.02 | -0.15 |
| Gross Margin | 100.0% | 100.0% | 100.0% | — | 100.0% |
| Operating Margin | 7.3% | 7.3% | -91.6% | — | -5452.0% |
| Net Margin | 6.0% | 6.0% | 6.1% | — | -2128.0% |
| Balance Sheet | |||||
| Current Ratio | 3.02 | 3.02 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $8.9M | $8.9M | $-5.0M | $-3.5M | $-4.2M |
| Returns | |||||
| ROE | 0.2% | 0.2% | 0.2% | -0.1% | -1.1% |
| Valuation | |||||
| P/E | 354.50 | 354.50 | 235.00 | — | — |
| EV/EBITDA | 36.11 | 36.11 | 31.13 | 46.79 | 135.10 |
| P/B | 0.50 | 0.50 | 0.38 | 0.38 | 0.37 |
| Growth & Yield | |||||
| Revenue Growth | -1.7% | -1.7% | — | — | — |
| EPS Growth | — | — | 200.0% | 86.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+41.8%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → n/d
Residual
+41.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.